Our find-ings indicate that serum adiponectin level is likely to be an adequate marker for deter-mination of the degree of insulin resistance, and may be a predictor of diseases, such astype 2 diabetes mellitus (T2DM) and metabolic syndrome, which develop on the basisof insulin resistance. Here, ADIPOQ is linked to metabolic syndrome.